Literature DB >> 9298665

The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients.

H Leverstein1, R M Tiwari, G B Snow, J E van der Wal, I van der Waal.   

Abstract

From 1974 to 1995, 40 patients were treated surgically at the University Hospital Vrije, Universiteit Amsterdam for recurrent or residual pleomorphic adenomas of the parotid gland after previous surgery. The median interval between the initial procedure and surgery for the recurrence was 122 months. Eleven patients had one or more attempts to resect tumor recurrences prior to referral. During reoperation at this institution it was decided to refrain from tumor resection in three patients. Tumor control in two of these patients was achieved using radiotherapy. In the third patient a "wait-and-see" policy was adopted. The other 37 patients underwent en bloc surgical excisions of their tumor and/or previously incised tissues. Among the 36 patients operated for histopathologically benign disease, 16 received postoperative radiotherapy (to 6500 cGy). None developed a further recurrence, the median follow-up being 106 months. Only one of these patients experienced permanent segmental facial nerve paralysis. Malignant transformation of tumor occurred in two patients. One of these patients died of locoregional disease after surgery and radiotherapy. Radical tumor resection was deferred in the other patient, with tumor control achieved using radiotherapy (7000 cGy). However, since recurrent disease tends to be multifocal in origin, prolonged routine follow-up is required.

Entities:  

Mesh:

Year:  1997        PMID: 9298665     DOI: 10.1007/BF02630721

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


  31 in total

1.  The Treatment of Tumours of the Salivary Glands by Radical Excision.

Authors:  R M Janes
Journal:  Can Med Assoc J       Date:  1940-12       Impact factor: 8.262

Review 2.  Should radiotherapy be used routinely in the management of benign parotid tumours?

Authors:  G T Watkin; M Hobsley
Journal:  Br J Surg       Date:  1986-08       Impact factor: 6.939

3.  Malignancy in pleomorphic adenoma. A clinical and microspectrophotometric study.

Authors:  C M Eneroth; A Zetterberg
Journal:  Acta Otolaryngol       Date:  1974-06       Impact factor: 1.494

4.  Problems with reoperation of the parotid gland and facial nerve.

Authors:  J J Conley
Journal:  Otolaryngol Head Neck Surg       Date:  1988-11       Impact factor: 3.497

5.  Recurrent pleomorphic adenoma of the parotid.

Authors:  W B Fleming
Journal:  Aust N Z J Surg       Date:  1987-03

6.  Recurrent pleomorphic adenomas of the parotid gland.

Authors:  A G Maran; I J Mackenzie; R E Stanley
Journal:  Arch Otolaryngol       Date:  1984-03

7.  Recurrent pleomorphic adenoma.

Authors:  S R Jackson; N J Roland; R W Clarke; A S Jones
Journal:  J Laryngol Otol       Date:  1993-06       Impact factor: 1.469

Review 8.  Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature.

Authors:  P P Phillips; K D Olsen
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-02       Impact factor: 1.547

9.  Management of pleomorphic adenoma of the parotid.

Authors:  J D Maynard
Journal:  Br J Surg       Date:  1988-04       Impact factor: 6.939

10.  Radiotherapy for pleomorphic adenoma of the parotid gland.

Authors:  J Barton; N J Slevin; E N Gleave
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

View more
  8 in total

Review 1.  Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature.

Authors:  Yen-Ling Kuo; Tzong-Yang Tu; Chia-Fan Chang; Wing-Yin Li; Shyue-Yih Chang; An-Suey Shiao; Pen-Yuan Chu; Kee-Tak Chan; Shyh-Kuan Tai; Yi-Fen Wang; Shu-Ching Kao; Shou-Yen Kao; Wen-Liang Lo; Cheng-Hsien Wu; Wen-Hu Shu; Shu Ma; Tien-Hsiang Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-01       Impact factor: 2.503

2.  Multinodular neck recurrence of parotid gland pleomorphic adenoma: a case report.

Authors:  Nick Papadogeorgakis; Evagelos F Kalfarentzos; Vassilis Petsinis; Eleni Parara; Maria-Emmanouela Kopaka
Journal:  Oral Maxillofac Surg       Date:  2011-06-10

Review 3.  Diseases of the salivary glands in infants and adolescents.

Authors:  Maik Ellies; Rainer Laskawi
Journal:  Head Face Med       Date:  2010-02-15       Impact factor: 2.151

4.  Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.

Authors:  T Hamada; S Matsukita; M Goto; S Kitajima; S K Batra; T Irimura; K Sueyoshi; K Sugihara; S Yonezawa
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

5.  Pleomorphic adenoma of the submandibular gland: an evolving change in practice following review of a personal case series.

Authors:  Nazia Munir; Patrick J Bradley
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-05       Impact factor: 2.503

6.  Pleomorphic adenoma of the buccal salivary gland.

Authors:  Shubhangi Khandekar; Alka Dive; Prashant Munde; Neena Dongre Wankhede
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr

7.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

8.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature.

Authors:  Luca Oscar Redaelli de Zinis; Michela Piccioni; Antonino Roberto Antonelli; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.